Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

Related Citations for PubMed (Select 21191178)

1.

Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk.

Pelletier C, Speed WC, Paranjape T, Keane K, Blitzblau R, Hollestelle A, Safavi K, van den Ouweland A, Zelterman D, Slack FJ, Kidd KK, Weidhaas JB.

Cell Cycle. 2011 Jan 1;10(1):90-9. Epub 2011 Jan 1.

2.

Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site.

Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B; kConFab, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P.

Hum Mutat. 2012 Dec;33(12):1665-75. doi: 10.1002/humu.22159. Epub 2012 Aug 2.

PMID:
22753153
3.

Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.

Lheureux S, Lambert B, Krieger S, Legros A, Vaur D, Denoyelle C, Berthet P, Poulain L, Hardouin A.

Breast Cancer Res Treat. 2011 Feb;125(3):885-91. doi: 10.1007/s10549-010-1165-8. Epub 2010 Sep 17.

PMID:
20848184
4.

Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.

Hollestelle A, Pelletier C, Hooning M, Crepin E, Schutte M, Look M, Collee JM, Nieuwlaat A, Dorssers LC, Seynaeve C, Aulchenko YS, Martens JW, van den Ouweland AM, Weidhaas JB.

Breast Cancer Res Treat. 2011 Jul;128(1):79-84. doi: 10.1007/s10549-010-1080-z. Epub 2010 Jul 30.

5.

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI.

Fam Cancer. 2009;8(1):15-22. doi: 10.1007/s10689-008-9205-9. Epub 2008 Aug 5.

PMID:
18679828
6.

A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.

Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, Altshuler D, Haiman CA.

Cancer Res. 2005 Aug 15;65(16):7516-22.

7.

Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.

Erturk E, Cecener G, Polatkan V, Gokgoz S, Egeli U, Tunca B, Tezcan G, Demirdogen E, Ak S, Tasdelen I.

Asian Pac J Cancer Prev. 2014;15(19):8319-24.

8.

Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response.

Chen W, Wang S, Ma Y, Zhou Y, Liu H, Strnad P, Kraemer FB, Krauss RM, Liu J.

Int J Mol Med. 2008 Mar;21(3):345-53.

PMID:
18288382
9.

The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation.

Jakubowska A, Gronwald J, Górski B, Huzarski T, Byrski T, Benner A, Lubiński J, Scott RJ, Hamann U.

Breast Cancer Res Treat. 2007 Jul;104(1):67-74. Epub 2006 Sep 27.

PMID:
17004108
10.

A germline mutation in the BRCA1 3'UTR predicts Stage IV breast cancer.

Dorairaj JJ, Salzman DW, Wall D, Rounds T, Preskill C, Sullivan CA, Lindner R, Curran C, Lezon-Geyda K, McVeigh T, Harris L, Newell J, Kerin MJ, Wood M, Miller N, Weidhaas JB.

BMC Cancer. 2014 Jun 10;14:421. doi: 10.1186/1471-2407-14-421.

11.

Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Cheng I, Penney KL, Stram DO, Le Marchand L, Giorgi E, Haiman CA, Kolonel LN, Pike M, Hirschhorn J, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1993-7.

12.

Genetic variants and haplotype analyses of the ZBRK1/ZNF350 gene in high-risk non BRCA1/2 French Canadian breast and ovarian cancer families.

Desjardins S, Belleau P, Labrie Y, Ouellette G, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M; INHERIT BRCAs, Durocher F.

Int J Cancer. 2008 Jan 1;122(1):108-16.

PMID:
17764113
13.

The mannose-binding lectin (MBL2) haplotype and breast cancer: an association study in African-American and Caucasian women.

Bernig T, Boersma BJ, Howe TM, Welch R, Yadavalli S, Staats B, Mechanic LE, Chanock SJ, Ambs S.

Carcinogenesis. 2007 Apr;28(4):828-36. Epub 2006 Oct 27.

14.

Germline RAP80 mutations and susceptibility to breast cancer.

Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA.

Breast Cancer Res Treat. 2009 Jan;113(2):377-81. doi: 10.1007/s10549-008-9938-z. Epub 2008 Feb 28.

PMID:
18306035
15.

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.

Sinilnikova OM, Ginolhac SM, Magnard C, Léoné M, Anczukow O, Hughes D, Moreau K, Thompson D, Coutanson C, Hall J, Romestaing P, Gérard JP, Bonadona V, Lasset C, Goldgar DE, Joulin V, Venezia ND, Lenoir GM.

Carcinogenesis. 2004 Dec;25(12):2417-24. Epub 2004 Aug 27.

17.

A functional polymorphism at 3'UTR of the PAX6 gene may confer risk for extreme myopia in the Chinese.

Liang CL, Hsi E, Chen KC, Pan YR, Wang YS, Juo SH.

Invest Ophthalmol Vis Sci. 2011 Jun 1;52(6):3500-5. doi: 10.1167/iovs.10-5859.

18.
19.

Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.

Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, Uhrhammer N, Bignon YJ, Troudi W, Elgaaied AB, Hassen E, Chouchane L.

Mol Biol Rep. 2012 Feb;39(2):1037-46. doi: 10.1007/s11033-011-0829-8. Epub 2011 May 21.

20.

BRCA1, microRNAs and cancer predisposition: challenging the dogma.

Almeida MI, Reis RM, Calin GA.

Cell Cycle. 2011 Feb 1;10(3):377. Epub 2011 Feb 1. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk